How PICO prediction supports JCA strategy and submission

Last updated: April 3rd, 2026

PICO prediction supported joint clinical assessment (JCA) strategy for a precision oncology launch across priority European markets. Early insight clarified the most likely assessment scope and enabled alignment of evidence strategy ahead of submission, helping teams plan with greater confidence under evolving JCA requirements.

By applying a structured and forward‑looking approach, Acumetis helped reframe what’s possible in how teams prepare for assessment, moving from reactive interpretation to earlier strategic clarity.

Technical expertise supporting JCA strategy

Specialist expertise in market access, health economics, and clinical strategy informs PICOs prediction, ensuring that assumptions reflect HTA methodology and real-world decision-making contexts relevant to the Joint Clinical Assessment.

Predicting likely PICOs for JCA scope
A structured evidence review identifies patient populations, comparators, and outcomes likely to fall within JCA scope, supporting early clarity on assessment focus areas.

1. Targeted literature review captures current and emerging comparators.
2. Analogue assessment incorporates oncologist insight on treatment positioning.
3. Focused desk research identifies relevant analogues and future comparators.

Prioritizing PICO across markets
Validation with country advisors supports market-level prioritization and highlights PICO scenarios that require deeper evidence consideration or strategic focus.

Practical agility supporting delivery

An iterative and flexible approach supports progress under compressed timelines while maintaining analytical rigor and alignment with evolving development and access priorities.

1. Identifying evidence gaps and mitigation strategies: The available evidence is reviewed against the predicted PICOs to identify gaps. Targeted analyses (AI-assisted SLR and NMA) support practical recommendations to strengthen alignment with Joint Clinical Assessment requirements.
2. Delivering results: Prioritized PICOs inform evidence planning and aligns predictive insights with broader development and access objectives, supporting a more efficient and coordinated JCA process.
3. Validating PICOs through expert engagement: Clinical expert input informs initial PICOs assumptions. Payer perspectives support confirmation of final PICOs selections aligned with assessment expectations.

Our expert support

By bringing early clarity to PICO scope and aligning evidence strategy ahead of submission, Acumetis helped teams move from interpretation to intention. This approach supported a more efficient, coordinated JCA preparation process and reframed what’s possible in how evidence, access, and strategic decisions come together under evolving European assessment requirements.